Abstract:Neutrophil extracellular traps (NETs) are web-like extrusions of genetic material, which are released upon neutrophil activation. NETs consist of a chromatin substructure, onto which a vast array of proteins with various properties is dispersed. NETs production was initially described as an unrecognized defense mechanism of neutrophils, due to their ability to entrap and possibly eliminate a wide range of pathogens. Nevertheless, growing evidence suggests that NETs are implicated in a multitude of pathophysiological conditions, such as autoimmunity, cancer, diabetes mellitus and Alzheimer's disease. Importantly, NETs may also play a decisive role in atherosclerosis and thrombosis. In this context, it has been demonstrated that NETs are present in atherosclerotic lesions of both humans and animal models and are implicated in various mechanisms leading to atherogenesis. Among others, NETs induce oxidative stress and oxidize high-density lipoprotein particles, thus reducing their beneficial cholesterol efflux capacity. NETs also induce endothelial cell dysfunction and apoptosis and promote the generation of anti-double-stranded-DNA autoantibodies. NETs may also play a prothrombotic role, since they form a fibrin-like base for platelet adhesion, activation and aggregation. Furthermore, NETs promote the accumulation of prothrombotic molecules, like von Willebrand factor and fibrinogen, thus significantly contributing to thrombus formation. Notably, there is vast data linking NETs to arterial and venous thrombosis in animal models, as well as in humans. Future large-scale studies should incorporate NETs and their individual components as disease markers, as well as potential therapeutic targets, to reduce atherosclerosis and to prevent thrombosis.

At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases

Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses

Autoimmune, rheumatic, chronic inflammatory diseases: Neutrophil extracellular traps on parade

Advances in neutrophil extracellular traps in systemic juvenile idiopathic arthritis

Neutrophil Extracellular Traps and Their Implications in Cardiovascular and Inflammatory Disease

Neutrophil Function in an Inflammatory Milieu of Rheumatoid Arthritis

The Pathophysiological Role of Neutrophil Extracellular Traps in Inflammatory Diseases

Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus

The Expanding Role of Extracellular Traps in Inflammation and Autoimmunity: The New Players in Casting Dark Webs

The role of neutrophil extracellular traps in inflammatory rheumatic diseases

Neutrophil Extracellular Traps in Inflammatory and Autoimmune Diseases and Cancer

New Insights into Neutrophil Extracellular Traps: Mechanisms of Formation and Role in Inflammation

The emerging role of neutrophil extracellular traps in the progression of rheumatoid arthritis

Neutrophil extracellular traps in homeostasis and disease

Neutrophils in autoimmunity: when the hero becomes the villain

The emerging role of neutrophils in autoimmune‐associated disorders: effector, predictor, and therapeutic targets

The Role of Neutrophil Extracellular Traps in Central Nervous System Diseases and Prospects for Clinical Application

Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2

Crossroads: Pathogenic role and therapeutic targets of neutrophil extracellular traps in rheumatoid arthritis

Neutrophil Extracellular Traps Affecting Cardiovascular Health in Infectious and Inflammatory Diseases

The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis